Cargando…
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients
INTRODUCTION: Patients with advanced non-small cell lung cancer (NSCLC) are most of the time treated with a first-line cytotoxic chemotherapy. Tobacco use is responsible for 90% of lung cancer. The aim of this study was to evaluate the impact of smoking continuation during first-line chemotherapy on...
Autores principales: | Dacosta-Noble, Philippine, Costantini, Adrien, Dumenil, Coraline, Dumoulin, Jennifer, Helly de Tauriers, Pierre, Giraud, Violaine, Labrune, Sylvie, Emile, Jean-François, Alvarez, Jean-Claude, Chinet, Thierry, Giroux Leprieur, Etienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602197/ https://www.ncbi.nlm.nih.gov/pubmed/31260495 http://dx.doi.org/10.1371/journal.pone.0219080 |
Ejemplares similares
-
Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab
por: Ouaknine Krief, Julia, et al.
Publicado: (2019) -
Clinical factors associated with early progression and grade 3–4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab
por: Dumenil, Coraline, et al.
Publicado: (2018) -
Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration
por: Wang, Lei, et al.
Publicado: (2017) -
Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression
por: Giroux Leprieur, Etienne, et al.
Publicado: (2020) -
Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer
por: Mehlman, Camille, et al.
Publicado: (2021)